Entering text into the input field will update the search result below

NFJ: Non-Leveraged Hybrid Fund At A Wide Discount


  • NFJ takes an approach of primarily investing in equity investments but also incorporates convertible securities.
  • The fund has managers from both NFJ Investment Group and Voya Investment Management.
  • The fund's discount is fairly attractive, and the fund also isn't leveraged, which can be appealing in this current environment.
  • This idea was discussed in more depth with members of my private investing community, CEF/ETF Income Laboratory. Learn More »

Pie chart in 3 option blue blank background

photoman/iStock via Getty Images

Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on March 16th, 2023.

Virtus Dividend Interest & Premium Strategy Fund (NYSE:NFJ) was previously

NFJ Performance Since Previous Update

NFJ Performance Since Previous Update (Seeking Alpha)

NFJ Annualized Performance

NFJ Annualized Performance (Virtus)







NFJ Distribution History

NFJ Distribution History (CEFConnect)

NFJ Semi-Annual Report

NFJ Semi-Annual Report (Virtus)

NFJ Distribution Tax Classification 2022

NFJ Distribution Tax Classification 2022 (Virtus)

NFJ Asset Allocation

NFJ Asset Allocation (Virtus)

NFJ Equity Exposure

NFJ Equity Exposure (Virtus)

NFJ Fixed-Income Exposure

NFJ Fixed-Income Exposure (Virtus)

NFJ Top Ten Holdings

NFJ Top Ten Holdings (Virtus)



SWK Earnings Past And Projections

SWK Earnings Past And Projections (Portfolio Insight)

Profitable CEF and ETF income and arbitrage ideas

https://static.seekingalpha.com/uploads/2019/5/2/27546953-15567808556447084.pngAt the CEF/ETF Income Laboratory, we manage ~8%-yielding closed-end fund (CEF) and exchange-traded fund (ETF) portfolios to make income investing easy for you. Check out what our members have to say about our service.

To see all that our exclusive membership has to offer, sign up for a free trial by clicking on the button below!

This article was written by

Nick Ackerman profile picture
CEF/ETF income and arbitrage strategies, 8%+ portfolio yields
Nick Ackerman is an avid student of the markets and has been investing in his own accounts for over 14 years. He is a former Financial Advisor and has previously qualified for holding Series 7 and Series 66 licenses. These licenses also specifically qualified him for the role of Registered Investment Adviser (RIA), i.e., he was registered as a fiduciary and could manage assets for a fee and give advice. Since then he has continued with his passion for investing through writing for Seeking Alpha, providing his knowledge, opinions, and insights of the investing world. His specific focus is on closed-end funds as an attractive way to achieve income as well as general financial planning strategies towards achieving one’s long term financial goals.


I provide my work regularly to CEF/ETF Income Laboratory with articles that have an exclusivity period, this is noted in such articles. CEF/ETF Income Laboratory is a Marketplace Service provided by Stanford Chemist, right here on Seeking Alpha.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ETV, MSFT, JPM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.